[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:
20-Mar-2014

[ | E-mail ] Share Share

Contact: Femke Buisman-Pijlman
femke.buisman-pijlman@adelaide.edu.au
61-883-135-989
University of Adelaide
www.twitter.com/UniofAdelaide

Can 'love hormone' protect against addiction?

IMAGE: This is an online-quality graphic showing factors influencing the oxytocin system and its link to addiction.

Click here for more information.

Addictive behavior such as drug and alcohol abuse could be associated with poor development of the so-called "love hormone" system in our bodies during early childhood, according to researchers at the University of Adelaide.

The groundbreaking idea has resulted from a review of worldwide research into oxytocin, known as the "love hormone" or "bonding drug" because of its important role in enhancing social interactions, maternal behavior and partnership.

This month's special edition of the international journal Pharmacology, Biochemistry and Behavior deals with the current state of research linking oxytocin and addiction, and has been guest edited by Dr Femke Buisman-Pijlman from the University of Adelaide's School of Medical Sciences.

Dr Buisman-Pijlman, who has a background in both addiction studies and family studies, says some people's lack of resilience to addictive behaviors may be linked to poor development of their oxytocin systems.

"We know that newborn babies already have levels of oxytocin in their bodies, and this helps to create the all-important bond between a mother and her child. But our oxytocin systems aren't fully developed when we're born they don't finish developing until the age of three, which means our systems are potentially subject to a range of influences both external and internal," Dr Buisman-Pijlman says.

She says the oxytocin system develops mainly based on experiences.

"The main factors that affect our oxytocin systems are genetics, gender and environment. You can't change the genes you're born with, but environmental factors play a substantial role in the development of the oxytocin system until our systems are fully developed," Dr Buisman-Pijlman says.

IMAGE: This photo shows Dr. Femke Buisman-Pijlman from the University of Adelaide. She is the guest editor of the April 2014 edition of Pharmacology, Biochemistry and Behavior, which is focused on...

Click here for more information.

"Previous research has shown that there is a high degree of variability in people's oxytocin levels. We're interested in how and why people have such differences in oxytocin, and what we can do about it to have a beneficial impact on people's health and wellbeing," she says.

She says studies show that some risk factors for drug addiction already exist at four years of age. "And because the hardware of the oxytocin system finishes developing in our bodies at around age three, this could be a critical window to study. Oxytocin can reduce the pleasure of drugs and feeling of stress, but only if the system develops well."

Her theory is that adversity in early life is key to the impaired development of the oxytocin system. "This adversity could take the form of a difficult birth, disturbed bonding or abuse, deprivation, or severe infection, to name just a few factors," Dr Buisman-Pijlman says.

"Understanding what occurs with the oxytocin system during the first few years of life could help us to unravel this aspect of addictive behavior and use that knowledge for treatment and prevention."

###

Media Contact:

Dr Femke Buisman-Pijlman
Senior Lecturer
Discipline of Pharmacology
School of Medical Sciences
The University of Adelaide
Phone: +61 8 8313 5989
femke.buisman-pijlman@adelaide.edu.au



[ Back to EurekAlert! ] [ | E-mail Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.